FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Noven Pharmaceuticals Minivelle Recall

Minivelle (estradiol transdermal system) Patches Delivers 0

Noven Pharmaceuticals, Inc. · Miami, FL

Risk level
Class II
Reported by FDA
Oct 3, 2018
Recall ID
D-1207-2018
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Minivelle starting Sep 7, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1207-2018 on Oct 3, 2018. Reason: Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. Status: Terminated.

Why it was recalled

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Product description

Minivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 count and b) 8 count boxes, Rx only, , Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6610-8

Lot numbers, UPCs & expiration codes

a) 82200 Exp. 01/2019 b) 81637 Exp. 10/2018; 82200 Exp. 01/2019; 82293 Exp. 02/2019; 82600 Exp. 04/2019; 83027 Exp. 04/2019; 83173 Exp. 06/2019; 83396 Exp. 09/2019

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1207-2018
Classification
Class II
Status
Terminated
Recall initiated
Sep 7, 2018
FDA report date
Oct 3, 2018
Quantity
213714 boxes of 8 patches and 15927 boxes of 2 patches
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1207-2018, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Terminated
Country
United States
Event ID
80997
Address
11960 SW 144th St
Code information
a) 82200 Exp. 01/2019 b) 81637 Exp. 10/2018; 82200 Exp. 01/2019; 82293 Exp. 02/2019; 82600 Exp. 04/2019; 83027 Exp. 04/2019; 83173 Exp. 06/2019; 83396 Exp. 09/2019
Postal code
33186-6109
Report date
Oct 3, 2018
Product type
Drugs
Recall number
D-1207-2018
Classification
Class II
Recalling firm
Noven Pharmaceuticals, Inc.
Product quantity
213714 boxes of 8 patches and 15927 boxes of 2 patches
Termination date
Sep 9, 2020
Reason for recall
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Minivelle (estradiol transdermal system) Patches Delivers 0.1 mg/day, a) 2 count and b) 8 count boxes, Rx only, , Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6610-8
Distribution pattern
Nationwide
Recall initiation date
Sep 7, 2018
Initial firm notification
Letter
Center classification date
Sep 25, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1207-2018, published Oct 3, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls